Work

A Phase II Trial of Lenalidomide, Cyclophosphamide and Dexamethasone (RCD) in Patients with Light Chain Amyloidosis.

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.3853.3853

Authors: Shaji Kumar, Suzanne R. Hayman, Francis Buadi, Jacob Allred, Kristina Laumann, Vivek Roy, Martha Q. Lacy, Morie A Gertz, Kristin Detweiler, Ann Birgin, Leif Bergsagel, David Dingli, Joseph R. Mikhael, Craig B. Reeder, A. Keith Stewart, Steven R. Zeldenrust, S. Vincent Rajkumar, Angela Dispenzieri

Institutions: Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic in Arizona

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2570623469

FWCI: 2.166

Cites:

Cited by: 21

Related to: 10